HFE mutations in African-American women with non-insulin-dependent diabetes mellitus

Ethnicity and Disease

Volumn 11, Issue 4, 2001, Pages 578-584

  Acton, Ronald T ^a,b,c,e   Barton, James C ^b,d   Bell, David S H ^b   Go, Rodney C P ^c   Roseman, Jeffrey M ^b,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d SOUTHERN IRON DISORDERS CENTER   (United States)

^e Kaul 420 ^*  (United States)

Author keywords

African Americans; Diabetes Mellitus; Hemochromatosis; HFE; Iron; Iron Overload

Indexed keywords

HFE PROTEIN, HUMAN; HLA A ANTIGEN; HLA A ANTIGENS; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA B ANTIGENS; IRON;

ADULT; ARTICLE; BLOOD; CHROMOSOME 6; FEMALE; GENE FREQUENCY; GENETICS; HUMAN; IRON OVERLOAD; MUTATION; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PREGNANCY DIABETES MELLITUS;

ADULT; BLACKS; CHROMOSOMES, HUMAN, PAIR 6; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DIABETES, GESTATIONAL; FEMALE; GENE FREQUENCY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMAN; IRON; IRON OVERLOAD; MUTATION; PREGNANCY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035460787     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably health blood donors. N Engl J Med. 1988;318:1355-1362.
2. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice parameter for hereditary hemochromatosis. Clin Chim Acta. 1996;245: 139-200.
3. Simon M, Pawlotsky Y, Bourel M, Fauchet R, Genetet B. Hemochromatose idiopathique: maladie associée a l'antigene tissulaire HL-A3? Nouv Presse Med. 1975;4:143.
4. Simon M, Le Mignon L, Fauchet R, et al. A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) Mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) Hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am J Hum Genet. 1987;41: 89-105.
5. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class-I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet. 1996;14: 399-408.
6. Barton JC, Sawada-Hirai R, Rothenberg BE, Acton RT. Two novel missense mutations of the HFE gene (HOST and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol Dis. 1999;25:146-154.
7. Douabain V, Moirand R, Jouanolle A, et al. Polymorphisms in the HFE gene. Hum Hered. 1999; 49:21-26.
8. Bernard PS, Ajioka RS, Kushner JP, Wittwer CT. Homogeneous multiplex genotyping of hemochromatosis mutations with fluorescent hybridization probes. Am J Pathol. 1998;153:1055-1061.
9. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997;34: 275-278.
10. Cullen LM, Gao X, Easteal S, Jazwinska C. The hemochromatosis 845 G/A and 187 C/G mutations: prevalence in non-Caucasian populations. Am J Hum Genet. 1998;62:1403-1407.
11. Mortimore M, Merryweather-Clarke AT, Robson KJH, Powell LW. The haemochromatosis gene: a global perspective and implications for the Asia-Pacific region. J Gastroenterol Hepatol. 1999;14: 838-843.
12. Marshall DS, Linfert DR, Tsongalis GJ. Prevalence of the C282Y and H63D polymorphisms in a multi-ethnic control population. Int J Mol Med. 1999;4:389-393.
13. Monaghan KG, Rybicki BA, Shurafa M, Feldman GL. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans. Am J Hematol. 1998;58:213-217.
14. MacClenahan K, Moran R, McDermott S, Longshore JW. Prevalence of hereditary hemochromatosis mutations in the Upper Savannah region of South Carolina. Proc Greenwood Genet Center. 2000;19:45-50.
15. Gordeuk VR, Mukiibi J, Hasstedt SJ, et al. Iron overload in Africa: interaction between a gene and dietary iron content. N Engl J Med. 1992;326:95-100.
16. Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL. Iron overload in African Americans. Am J Med. 1995;99:616-623.
17. Wurapa RK, Gordeuk VR, Brittenham GM, Khiyami A, Schlechter GP, Edwards CQ. Primary iron overload in African Americans. Am J Med. 1996; 101:9-18.
18. Moyo VM, Mandishona E, Hasstedt S, et al. Evidence for genetic transmission in African iron overload. Blood. 1998;91:1076-1082.
19. Barton JC, Acton RT, Edwards CQ, et al. Iron overload in African Americans: phenotypic and genotypic characterization of probands from central Alabama. Molecular Medicine and Hemochromatosis, NIH. 1998:43-45.
20. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology. 1997;25:162-166.
21. Phelps G, Chapman I, Hall P, Braund W, Mackinnon M. Prevalence of genetic haemochromatosis among diabetic patients. Lancet. 1989;2:233-234.
22. O'Brien T, Barrett B, Murray DM, Dinneen S, O'Sullivan DJ. Usefulness of biochemical screening of diabetic patients for hemochromatosis. Diabetes Care. 1990;13:532-534.
23. Czinx L, Tamas C. Screening for idiopathic hemochromatosis among diabetic patients. Diabetes Care. 1991;14:929.
24. George DK, Evans RM, Crofton RW, Gunn IR. Testing for haemochromatosis in the diabetic clinic. Ann Clin Biochem. 1999;32:521-526.
25. Dinneen SF, Silversberg JD, Batts KP, O'Brien PC, Ballard DJ, Rizza RA. Liver iron stores in patients with non-insulin-dependent diabetes mellitus. Mayo Clin Proc. 1994;69:13-15.
26. Turnbull AJ, Mitchison HC, Peaston RTP, et al. The prevalence of hereditary haemochromatosis in a diabetic population. Q J Med. 1997;90:271-275.
27. Aldersley MA, Allgar V, Howdle PD, Markham AF Haemochromatosis and type 2 diabetes. Lancet. 1998;352:1067-1068.
28. Salonen JT, Tuomainen T-P, Nyyssonen K, Lakka H-M, Punnonen K. Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ. 1998;317:727-729.
29. Conte D, Manachino D, Colli A, et al. Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med. 1998;128:370-373.
30. Braun J, Donner H, Plock K, Rau H, Usadel KH, Badenhoop K. Hereditary haemochromatosis mutations (HFE) in patients with type II diabetes mellitus. Diabetologia. 1998;41:983-984.
31. Hegele RA, Harris SB, Zinman B. Hemochromatosis and diabetes mellitus. Ann Intern Med. 1998; 129:587-589.
32. Dubois-Laforgue D, Caillat-Zucman S, Djilali-Saiah I, et al. Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM. Diabetes Care. 1998;21:1371-1372.
33. Florkowski CM, George PM, Willis JA, et al. Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in type 2 diabetic patients compared with the Canterbury (New Zealand) general population. Diab Res Clin Pract. 1999;43:199-203.
34. Behn PS, Glaser B, Permutt MA. Contribution of the C282Y hereditary hemochromatosis mutation to type 2 diabetes mellitus in Ashkenazi Jews. Diabetes. 1998;47(suppl 1):396.
35. Frayling T, Ellard S, Grove J, Walker M, Hattersley AT. C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes. Lancet. 1998; 351:1933-1934.
36. Kwan T, Leber B, Ahuja S, Carter R, Gerstein HC. Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene. Clin Invest Med. 1998;21:251-257.
37. Fernandez-Real J-M, Vendrell J, Baiget M, Gimferrer E, Ricart W. C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes. Diabetes Care. 1999;22:525-526.
38. Roseman JM, Go RCP, Perkins LL, et al. Gestational diabetes mellitus among African-American women. Diabetes Metab Rev. 1991;7:93-104.
39. National Diabetes Data group: classification of diagnosis of diabetes mellitus and other categories of glucose tolerance. Diabetes. 1979;28:1039-1057.
40. Barton JC, Shih WWH, Sawada-Hirai R, et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis. 1997;23:135-145.
41. Stott MK, Fellowes AP, Upton JD, Burt MJ, George PM. Simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations. Clin Chem. 1999;45:426-429.
42. SAS Users Guide, Statistics, Version 6.12. Cary, NC: SAS Institute; 1997.
43. McNamara L, MacPhail AP, Gordeuk VR, Hasstedt SJ, Rouault T. Is there a link between African iron overload and the described mutations of the hereditary haemochromatosis gene? Br J Haematol. 1998:102:1176-1178.
44. Barton JC, Harman L, Rivers C, Acton RT. Hemochromatosis: association of severity of iron overload with genetic markers. Blood Cells Mol Dis. 1996;22:195-204.
45. Conrad M. Sickle cell disease and hemochromatosis. Am J Hematol. 1991;38:150-152.
46. Jazwinska EC. The ancestral haplotype in hemochromatosis. In: Barton JC, Edwards CQ, eds. Hemochromatosis. Genetics, Pathophysiology, Diagnosis and Treatment. Cambridge, England: Cambridge University Press; 2000:91-98.
47. Acton RT, Harman L, Go RCP, Tseng M-L, Bias W. Comparison of HLA phenotypes among African Americans from Alabama, Maryland, and North Carolina. Transplant Proc. 1993;25:2404-2407.
48. Pittman WB, Acton RT, Barger BO, et al. HLA-A, -B, and -DR associations in type 1 diabetes mellitus with onset after age forty. Diabetes. 1982; 31:122-125.
49. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991 Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford, England: Oxford University Press; 1992:1065-1220.
50. Thomas H. The Slave Trade. New York, NY: Simon & Schuster; 1997.
51. Reitnauer PJ, Go RCP, Acton RT, et al. Evidence for genetic admixture as a determinant in the occurrence of insulin-dependent diabetes mellitus in US Blacks. Diabetes. 1982;31:532-537.
52. Roth M, Giraldo P, Hariti G, et al. Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethiopia, and Senegal. Immunogenetics. 1997;46:222-225.
53. Jeffery S, Crosby A, Plange-Rhule J, et al. Evidence from a Ghanaian population of known African descent to support the proposition that hemochromatosis is a Caucasian disorder. Genet Testing. 1999;3:375-377.
54. Parra EJ, Marcini A, Akey J, et al. Estimating African-American admixture proportions by use of population-specific alleles. Am J Hum Genet. 1998;63:1839-1851.